| 1 |
Atkins D, Best D, Briss PA, et al.Grading quality of evidence and strength of recommendations[J]. BMJ, 2004, 328(7454): 1490.
|
| 2 |
Atkins D, Briss PA, Eccles M, et al.Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system[J]. BMC Health Serv Res, 2005, 5(1): 25.
|
| 3 |
Phipps CD, Wood WE, Gibson WS, et al.Gastroesophageal reflux contributing to chronic sinus disease in children: a prospective analysis[J]. Arch Otolaryngol Head Neck Surg, 2000, 126(7): 831-836.
|
| 4 |
Ylitalo R, Lindestad PA, Ramel S. Symptoms, laryngeal findings, and 24-hour pH monitoring in patients with suspected gastroesophago-pharyngeal reflux[J]. Laryngoscope, 2001, 111(10): 1735-1741.
|
| 5 |
Camilleri M, Dubois D, Coulie B, et al.Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study[J]. Clin Gastroenterol Hepatol, 2005, 3(6): 543-552.
|
| 6 |
Vakil NB, Traxler B, Levine D. Dysphagia in patients with erosive esophagitis: prevalence, severity, and response to proton pump inhibitor treatment[J]. Clin Gastroenterol Hepatol, 2004, 2(8): 665-668.
|
| 7 |
Gerson LB, Kahrilas PJ, Fass R. Insights into gastroesophageal refluxdisease-associated dyspeptic symptoms[J]. Clin Gastroenterol Hepatol, 2011, 9(10): 824-833.
|
| 8 |
Becher A, El-Serag H. Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease[J]. Aliment Pharmacol Ther, 2011, 34(6): 618-627.
|
| 9 |
Gerson LB, Fass R. A systematic review of the definitions, prevalence, and response to treatment of nocturnal gastroesophageal reflux disease[J]. Clin Gastroenterol Hepatol, 2009, 7(4): 372-378.
|
| 10 |
Becher A, Dent J. Systematic review: ageing and gastro-oesophageal reflux disease symptoms, oesophageal function and reflux oesophagitis[J]. Aliment Pharmacol Ther, 2011, 33(4): 442-454.
|
| 11 |
Johnson DA, Fennerty MB.Heartburn severity underestimates erosiveesophagitis severity in elderly patients with gastroesophageal reflux disease[J]. Gastroenterology, 2004, 126(3): 660-664.
|
| 12 |
Rubenstein JH, Scheiman JM, Sadeghi S, et al.Esophageal adenocarcinomaincidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies[J]. Am J Gastroenterol, 2011, 106(2): 254-260.
|
| 13 |
Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis[J]. Am J Gastroenterol, 2006, 101(11): 2619-2628.
|
| 14 |
Hampel H, Abraham NS, El-Serag HB.Meta-analysis: obesity and the riskfor gastroesophageal reflux disease and its complications[J]. Ann Intern Med, 2005, 143(3): 199-211.
|
| 15 |
Labenz J, Jaspersen D, Kulig M, et al.Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative[J]. Am J Gastroenterol, 2004, 99(9): 1652-1656.
|
| 16 |
Lagergren J, Bergstrom R, Nyren O. Association between body mass andadenocarcinoma of the esophagus and gastric cardia[J]. Ann Intern Med, 1999, 130(11): 883-890.
|
| 17 |
林三仁，许国铭，胡品津，等．中国胃食管反流病共识意见(2006年10月三亚)[J]．胃肠病学，2007，12(4)：233-239.
|
| 18 |
Kahrilas PJ, Hughes N, Howden CW.Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease[J]. Gut, 2011, 60(11): 1473-1478.
|
| 19 |
Hirano I, Richter JE.ACG practice guidelines: esophageal reflux testing[J]. Am J Gastroenterol, 2007, 102(3): 668-685.
|
| 20 |
Lux G, Van Els J, The GS, et al.Ambulatory oesophageal pressure, pH, and ECG recordings in patients with normal and pathological coronary angiography and intermittent chest pain[J]. Neurogastroenterol Motil, 1995, 7(1): 23-30.
|
| 21 |
Johnston BT, Troshinsky MB, Castell JA, et al.Comparison of barium radiology with esophageal pH monitoring in the diagnosis of gastroesophagealreflux disease[J]. Am J Gastroenterol, 1996, 91(6): 1181-1185.
|
| 22 |
Richter JE, Castell DO.Gastroesophageal reflux.Pathogenesis, diagnosis, and therapy[J]. Ann Intern Med, 1982, 97(1): 93-103.
|
| 23 |
Johnsson F, Joelsson B, Gudmundsson K, et al.Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease[J]. Scand J Gastroenterol, 1987, 22(6): 714-718.
|
| 24 |
Gerson LB, Boparai V, Ullah N, et al.Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett′s oesophagus treated with proton pump inhibitors[J]. Aliment Pharmacol Ther, 2004, 20(6): 637-643.
|
| 25 |
季锋，汪忠镐．高分辨率食管测压法在食管裂孔疝诊断中的意义[J]．中华普通外科杂志，2013，28(6)：427-430.
|
| 26 |
Yaghoobi M, Farrokhyar F, Yuan Y, et al.Is there an increased risk of GERD after Helicobacter pylori eradication？: a meta-analysis[J]. Am J Gastroenterol, 2010, 105(5): 1007-1013.
|
| 27 |
Malfertheiner P, Megraud F, O′Morain C, et al.Current concepts in the management of Helicobacter pylori infection: the Maastricht III ConsensusReport[J]. Gut, 2007, 56(6): 772-781.
|
| 28 |
Stanciu C, Bennett JR.Effects of posture on gastro-oesophageal reflux[J]. Digestion, 1977, 5(2): 104-109.
|
| 29 |
Hamilton JW, Boisen RJ, Yamamoto DT, et al.Sleeping on a wedge diminishes exposure of the esophagus to refluxed acid[J]. Dig Dis Sci, 1988, 33(5): 518-522.
|
| 30 |
Pollmann H, Zillessen E, Pohl J, et al.Effect of elevated head position in bed in therapy of gastroesophageal reflux[J]. Z Gastroenterol, 1996, 34(Suppl 2): 93-99.
|
| 31 |
Fraser-Moodie CA, Norton B, Gornall C, et al.Weight loss has an independent beneficial effect on symptoms of gastro-oesophageal reflux in patients who are overweight[J]. Scand J Gastroenterol, 1999, 34(4): 337-340.
|
| 32 |
Mathus-Vliegen LM, Tytgat GN.Twenty-four-hour pH measurements in morbid obesity: effects of massive overweight, weight loss and gastric distension[J]. Eur J Gastroenterol Hepatol, 1996, 8(7): 635-640.
|
| 33 |
Oelschlager BK, Quiroga E, Parra JD, et al.Long-term outcomes of the laparoscopic antireflux surgery[J]. Am J Gastroenterol, 2008, 103(2): 280-287.
|
| 34 |
Frazzoni M, Piccoli M, Conigliaro R, et al.Refractory gastroesophageal reflux disease as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication[J]. Surg Endosc, 2013, 27(8): 2940-2946.
|
| 35 |
季锋，汪忠镐，吴继敏，等．腹腔镜Nissen胃底折叠术治疗胃食管反流病110例报告[J]．中国微创外科杂志，2010，10(4)：351-356.
|
| 36 |
De Groot NL, Burgerhart JS, Van De Meeberg PC, et al.Systematic review: the effects of conservative and surgical treatment for obesity on gastrooesophageal reflux disease[J]. Aliment Pharmacol Ther, 2009, 30(11/12): 1091-1102.
|
| 37 |
Urbach DR, Horvath KD, Baxter NN, et al.A research agenda for gastrointestinal and endoscopic surgery[J]. Surg Endosc, 2007, 21(9): 1518-1525.
|
| 38 |
Testoni PA, Vailati C, Testoni S, et al.Transoral incisionless fundoplication(TIF 2.0)with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome[J]. Surg Endosc, 2012, 26(5): 1425-1435.
|
| 39 |
Witteman BP, Strijkers R, de Vries E, et al.Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice[J]. Surg Endosc, 2012, 26(11): 3307-3315.
|
| 40 |
Liang WT, Wu JM, Wang F, et al.Stretta radiofrequency for gastroesophageal reflux disease-related respiratory symptoms: a prospective 5-year study[J]. Minerva Chirurgica, 2014, 69(5): 293-299.
|
| 41 |
Ronkainen J, Aro P, Storskrubb T, et al.High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report[J]. Scand J Gastroenterol, 2005, 40(3): 275-285.
|
| 42 |
Barrison AF, Jarboe LA, Weinberg BM, et al.Patterns of proton pump inhibitor use in clinical practice[J]. Am J Med, 2001, 111(6): 469-473.
|
| 43 |
中华医学会消化病学分会．2014年中国胃食管反流病专家共识意见[J]．中华消化杂志，2014，34(10)：649-661.
|
| 44 |
宁雅婵，汪忠镐，吴继敏，等．胃食管反流病1014例住院患者的诊治分析[J/CD]．中华普外科手术学杂志：电子版，2010，4(3)：264-270.
|
| 45 |
Vela MF, Camacho-Lobato L, Srinivasan R, et al.Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole[J]. Gastroenterology, 2001, 120(7): 1599-1606.
|
| 46 |
Labenz J, Malfertheiner P. Treatment of uncomplicated reflux disease[J]. World J Gastroenterol, 2005, 11(28): 4291-4299.
|
| 47 |
Modiano N, Gerson LB.Risk factors for the detection of Barrett′s esophagus in patients with erosive esophagitis[J]. Gastrointest Endosc, 2009, 69(6): 1014-1020.
|
| 48 |
Stoltey J, Reeba H, Ullah N, et al.Does Barrett′s oesophagus develop over time in patients with chronic gastro-oesophageal reflux disease? [J]. Aliment Pharmacol Ther, 2007, 25(1): 83-91.
|
| 49 |
Altintas E, Kacar S, Tunc B, et al.Intralesional steroid injection in benign esophageal strictures resistant to bougie dilation[J]. J Gastroenterol Hepatol, 2004, 19(12): 1388-1391.
|
| 50 |
Sgouros SN, Vlachogiannakos J, Karamanolis G, et al.Long-term acid suppressive therapy may prevent the relapse of lower esophageal(Schatzki′s)rings: a prospective, randomized, placebo-controlled study[J]. Am J Gastroenterol, 2005, 100(9): 1929-1934.
|
| 51 |
Huang Q, Fang DC, Yu CG, et al.Barrett′s esophagus related diseases remain uncommon in China[J]. J Dig Dis, 2011, 12(6): 420-427.
|